Civica Rx was launched amidfanfare last year, backed by philanthropic donors and hundreds ofhospitals. (Photo: Getty)
A nonprofit founded to address a pressing U.S. health-careproblem by manufacturing much-needed drugs that have fallen intoshort supply, or that are too expensive, willstart out with a different approach: buying the drugs frompharmaceutical companies.
Civica Rx was launched amid fanfare last year, backed byphilanthropic donors and hundreds of hospitals. Fed up withshortages or skyrocketing prices for products like salinesolution and epinephrine, Civica said in September that it plannedto “directly manufacture generic drugs or sub-contractmanufacturing to reputable contract manufacturingorganizations.”
Continue Reading for Free
Register and gain access to:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
